Advances in cervical screening technology.
The Pap smear unquestionably is a successful screening test for cervical cancer. However, recent advances in technology have raised questions regarding whether the conventional Pap smear is still the standard of care. This article relates issues of screening and cost-effectiveness to the state of the art in thin layer preparations, cytology automation, human papillomavirus screening, human papillomavirus vaccines, and other cervical screening adjuncts. Perhaps nowhere in medicine is clinical decision making being more strongly influenced by market and other external forces than in cervical cytopathology.
Stoler
M H
MH
Department of Pathology, University of Virginia Health System, Charlottesville, USA.
D001331:Automation; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000295:instrumentation / Q000379:methods; D008403:Mass Screening / Q000191:economics / Q000295:instrumentation / Q000639:trends; D065006:Papanicolaou Test; D027383:Papillomaviridae / Q000276:immunology / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control; D014412:Tumor Virus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*; D014614:Vaccines, Synthetic; D014626:Vaginal Smears / Q000191:economics / Q000295:instrumentation / Q000639:trends; D014765:Viral Vaccines
D014614:Vaccines, Synthetic; D014765:Viral Vaccines